IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,893 | -41.2% | 11,405 | -9.1% | 0.03% | -38.5% |
| Q2 2023 | $88,296 | -3.7% | 12,542 | -16.4% | 0.05% | +4.0% |
| Q1 2023 | $91,705 | -30.9% | 15,009 | -27.8% | 0.05% | -27.5% |
| Q4 2022 | $132,797 | +2.2% | 20,782 | +53.7% | 0.07% | +32.7% |
| Q3 2022 | $130,000 | -12.2% | 13,519 | +0.8% | 0.05% | -5.5% |
| Q2 2022 | $148,000 | +2.8% | 13,415 | +54.9% | 0.06% | -14.1% |
| Q1 2022 | $144,000 | -17.7% | 8,663 | -5.7% | 0.06% | -3.0% |
| Q4 2021 | $175,000 | -20.1% | 9,182 | +3.2% | 0.07% | -31.2% |
| Q3 2021 | $219,000 | -10.2% | 8,901 | -5.0% | 0.10% | -4.0% |
| Q2 2021 | $244,000 | +29.1% | 9,371 | +56.9% | 0.10% | +25.0% |
| Q1 2021 | $189,000 | -30.5% | 5,971 | +1.7% | 0.08% | -29.2% |
| Q4 2020 | $272,000 | -20.9% | 5,870 | -43.8% | 0.11% | -37.2% |
| Q3 2020 | $344,000 | +5.5% | 10,450 | -12.0% | 0.18% | +16.9% |
| Q2 2020 | $326,000 | -20.9% | 11,869 | -13.7% | 0.15% | -9.4% |
| Q1 2020 | $412,000 | -5.5% | 13,751 | -12.8% | 0.17% | +139.4% |
| Q4 2019 | $436,000 | +80.9% | 15,764 | +19.2% | 0.07% | +44.9% |
| Q3 2019 | $241,000 | -29.5% | 13,225 | -5.3% | 0.05% | -31.9% |
| Q2 2019 | $342,000 | +28.6% | 13,962 | -53.6% | 0.07% | +60.0% |
| Q4 2018 | $266,000 | -34.5% | 30,077 | -16.7% | 0.04% | +7.1% |
| Q3 2018 | $406,000 | -48.8% | 36,120 | -41.7% | 0.04% | -94.0% |
| Q2 2018 | $793,000 | -48.4% | 61,951 | -31.9% | 0.70% | -47.5% |
| Q1 2018 | $1,537,000 | +377.3% | 90,926 | +125.9% | 1.33% | +230.2% |
| Q4 2017 | $322,000 | -23.9% | 40,259 | -26.2% | 0.40% | +608.8% |
| Q3 2017 | $423,000 | +16.2% | 54,523 | +10.1% | 0.06% | +5.6% |
| Q2 2017 | $364,000 | – | 49,536 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |